{ "schemaVersion": "deck-intelligence.v1", "id": "019dd923-622c-750b-8b9d-5bbf2c91b5c4", "slug": "839c06ad1c27", "title": "Valeant Pharmaceuticals International (VRX)", "subtitle": "Citron Research · 2015-10", "author": "Citron Research", "date": "2015-10-21 00:00:00", "pageCount": 8, "kind": "research-note", "orientation": "portrait", "aspectRatio": 0.77272725, "targetCompany": "Valeant Pharmaceuticals International", "targetTicker": "VRX", "document": { "id": "019dd923-622c-750b-8b9d-5bbf2c91b5c4", "slug": "839c06ad1c27", "title": "Valeant Pharmaceuticals International (VRX)", "rawTitle": "Valeant Philador and RandO final a", "authorId": "52_Citron_Research", "authorName": "Citron Research", "authorDisplay": "Citron Research", "kind": { "slug": "research-note", "label": "Research note" }, "sourceType": { "slug": "short_seller", "label": "Short seller" }, "fileName": "2015-10-Valeant-Philador-and-RandO-final-a.pdf", "sourceUrl": null, "sourceDate": "2015-10-21 00:00:00", "presentationDate": "2015-10-21 00:00:00", "ingestedAt": "2026-04-23 08:26:32+00", "status": "ready", "pageCount": 8, "orientation": "portrait", "aspectRatio": 0.77272725, "targetCompany": "Valeant Pharmaceuticals International", "targetTicker": "VRX", "metadata": { "local_root": "/tmp/legacy-images/839c06ad1c27", "activist_firm": "Citron Research", "origin_corpus": "contrarian", "extraction_seconds": 150.9012701511383 } }, "coverage": { "pageCount": 8, "pagesIndexed": 8, "pagesWithImages": 8, "pagesWithMetadata": 8, "imageCoveragePct": 100, "metadataCoveragePct": 100, "componentCount": 45, "chartCount": 0, "metricSlides": 0, "toolMatches": 2, "documentToolMatches": 2, "frameworkMatches": 6, "arcMatches": 1, "beatMatches": 2, "loopMatches": 2, "patternMatches": 0, "storymakersMatch": false, "scoreAvailable": false, "reviewAvailable": false, "activistThesisAvailable": true, "pitchdeckMetadataAvailable": false, "pitchdeckProfileAvailable": false }, "blocks": [], "matches": { "arcs": [ { "arc": { "name": "Overcoming the Monster", "slug": "overcoming-monster", "status": "active", "bestFor": "Competitive positioning, rallying teams", "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order", "description": null, "familyLabel": null, "categoryName": "Booker's 7 Plots", "categorySlug": "booker-s-7-plots" }, "matchId": "5693a768-917f-4653-b264-cf321b6c2750", "evidence": "The document follows a narrative of uncovering a hidden issue (the connection between Valeant and Philidor Rx Services and R&O Pharmacy) and presenting evidence to support this claim", "isPrimary": true, "confidence": 0.8, "extraction": { "at": "2026-07-16 22:04:09.719428+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "beats": [ { "to": 1, "arc": { "name": "Overcoming the Monster", "slug": "overcoming-monster", "status": "active", "bestFor": "Competitive positioning, rallying teams", "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order", "description": null, "familyLabel": null, "categoryName": "Booker's 7 Plots", "categorySlug": "booker-s-7-plots" }, "from": 1, "name": "Hook", "beatId": "84bf320e-4e89-448a-95ed-196717c0f56a", "matchId": "5693a768-917f-4653-b264-cf321b6c2750", "beatType": { "name": "Hook", "slug": "hook", "status": "active", "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5", "version": 1, "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster." }, "evidence": "The document begins with a provocative statement, 'Valeant: Could this be the Pharmaceutical Enron?'", "position": 0, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 }, { "to": 7, "arc": { "name": "Overcoming the Monster", "slug": "overcoming-monster", "status": "active", "bestFor": "Competitive positioning, rallying teams", "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order", "description": null, "familyLabel": null, "categoryName": "Booker's 7 Plots", "categorySlug": "booker-s-7-plots" }, "from": 3, "name": "Expose Contradiction", "beatId": "4ae2007e-94c8-4629-918a-6139bd346d3d", "matchId": "5693a768-917f-4653-b264-cf321b6c2750", "beatType": null, "evidence": "The document presents a series of contradictions and coincidences that suggest a connection between Valeant and Philidor Rx Services and R&O Pharmacy", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 4, "from": 3, "loop": { "name": "03_aha_moment", "slug": "03-aha-moment", "status": "active", "bestFor": "Data-heavy sections, research findings, analytical arguments", "canonId": "019dd956-66f4-7668-ab25-cec9c996c0bc", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "description": "Establish a tension, present data, then deliver the insight that changes everything", "familyLabel": null, "categoryName": "Narrative", "categorySlug": "narrative" }, "matchId": "96843e19-c8e5-42dc-a5c3-ed0b532f722e", "evidence": "The document presents evidence of identical contact information and phone routing, suggesting a connection between the entities", "position": 0, "objective": "What is the nature of the relationship between Valeant and Philidor Rx Services and R&O Pharmacy?", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:04:09.830593+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } }, { "to": 7, "from": 7, "loop": { "name": "05_the_reveal", "slug": "05-the-reveal", "status": "active", "bestFor": "Product launches, strategic pivots, unexpected findings", "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Setup the Question -> Build Suspense -> The Big Reveal", "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion", "familyLabel": null, "categoryName": "Narrative", "categorySlug": "narrative" }, "matchId": "21e4a757-d53c-4694-acc3-2922986a9e40", "evidence": "The document suggests that the connection between Valeant and Philidor Rx Services and R&O Pharmacy indicates potential wrongdoing", "position": 1, "objective": "What are the implications of this connection?", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:04:09.869248+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "tools": [ { "tool": { "name": "CEO quote contradiction", "slug": "ceo-quote-contradiction", "status": "active", "bestFor": "When management credibility is the lever", "canonId": "019dd9e1-52e9-717f-8454-93e627563ed6", "version": 1, "bodyDocId": "019dd9a1-8296-720d-8f51-da76937f9415", "description": "You reproduce management's own words — verbatim, with source and date — and\nthen place them next to the outcome that contradicts them. The CEO built\nthe rope; you put it around their own neck.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "document", "agents": null, "matchId": "c28496dc-cc12-40bb-b74e-d2b21c49026f", "evidence": null, "pageRefs": null, "priority": null, "whenToUse": "When management credibility is the lever", "confidence": null, "extraction": { "at": "2026-04-29 12:07:50.267697+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": null, "whyItWorks": "- **Maximum credibility**: no adjective you could write is as damning as the\n target's own prior statement.\n- **No rebuttal path**: management can't argue they didn't say it.\n- **It forces accountability onto a person**, not an institution — even if\n you aren't explicitly naming a villain elsewhere.\n- **Reporters amplify it**. A CEO-quote-contradiction slide is quotable,\n which means it lands in WSJ/FT/Bloomberg coverage.", "antipattern": null, "cardinality": null, "narrativePurpose": null }, { "tool": { "name": "Villain naming", "slug": "villain-naming", "status": "active", "bestFor": "When governance or specific decisions are the core thesis", "canonId": "019dd9e1-55a4-74db-9314-0ced4cd46cd2", "version": 1, "bodyDocId": "019dd9a1-88f1-72ad-8f4e-56ec29d7b369", "description": "You identify a **specific person** responsible for the target's underperformance\nor the behaviour you want changed — and name them. Not \"management\" or \"the\nboard\". A named executive or director with a specific failure attributable to\nthem.", "familyLabel": null, "categoryName": null, "categorySlug": null }, "agent": null, "layer": "document", "agents": null, "matchId": "b9c7d9bc-1ae5-47aa-9571-a0d937ec6d21", "evidence": "J. Michael Pearson (CEO); Norma Provencio (audit committee chair); Bill Ackman referenced as defender", "pageRefs": null, "priority": null, "whenToUse": "When governance or specific decisions are the core thesis", "confidence": null, "extraction": { "at": "2026-04-29 12:07:50.267697+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": null, "whyItWorks": "- **Accountability needs a face.** Voters (shareholders, regulators,\n journalists) act faster against people than institutions.\n- **Credibility rises with specificity.** \"The CFO has repeatedly missed\n guidance\" > \"Management has missed guidance\".\n- It **pre-empts evasion**. An individual can be removed; an abstraction\n cannot.\n- It **forces the target to respond personally** — and their defensive\n response usually generates more attention for your thesis.", "antipattern": null, "cardinality": null, "narrativePurpose": null } ], "frameworks": [ { "matchId": "60026a5d-49de-43c3-8de7-7a4ad08a65f1", "evidence": "The slide explicitly frames the company as a 'Pharmaceutical Enron' and alleges a 'cover up'.", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 19:52:38.089+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "frameworkName": "fraud-exposure" }, { "matchId": "7358d372-0955-4015-84d8-19118616afb4", "evidence": "The slide explicitly claims 'fraud to create invoices to deceive the auditors'", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 19:52:32.947+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "frameworkName": "fraud-exposure" }, { "matchId": "08a74e6b-f6d5-41cf-a26a-507c8121857b", "evidence": "The slide uses evidence of shared contact details to expose a hidden relationship between two entities.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:52:36.182+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "frameworkName": "fraud-exposure" }, { "matchId": "444500cf-bdbf-44c8-9768-5c13b4e22fb9", "evidence": "Direct comparison of executive quotes to highlight patterns of behavior.", "framework": null, "confidence": 0.95, "extraction": { "at": "2026-05-02 19:52:32.45+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "frameworkName": "ceo-quote-contradiction" }, { "matchId": "679ddaef-f18b-4b13-9dcc-11b9a97a11e6", "evidence": "Compares Valeant/Philidor situation to the historical Arthrocare/Discocare fraud case.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:52:34.361+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 7, "frameworkName": "argument-from-analogy" }, { "matchId": "e8a1d8d6-d53b-4c6e-b835-82e911f7bd13", "evidence": "Compares Valeant's situation to the Enron scandal involving Lay and Skilling.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:52:33.494+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "frameworkName": "metaphor-analogy" } ], "patterns": [] }, "storymakers": null, "score": null, "review": null, "activistThesis": { "tone": "adversarial", "notes": "Landmark Citron short report that catalyzed Valeant's collapse. Not a slide deck — a text-heavy research note with embedded evidence screenshots (Valeant's own investor slide about R&O, matched privacy-notice PDFs proving Philidor and R&O share management, same toll-free Privacy Officer number across clone pharmacies). Core rhetorical moves: (1) 'Smoking Gun' SCQA framing anchored on identical website boilerplate, (2) side-by-side Enron/Valeant CEO quote table on p6, (3) Skilling-vs-Pearson bio parallel (both ex-McKinsey, 0 yrs operating experience), (4) Arthrocare/Discocare historical analog with 'CEO now doing 20 years' kicker. Closes with Galileo epigraph and 'Extremely Cautious Investing to All' sign-off. Villain-naming extends beyond CEO to audit committee chair, citing Bronte Capital post on Signalife/Mitchell Stein association. No individual author credited on document (signed only 'Citron Research'; Andrew Left is the known founder but not named in the PDF). No formal valuation model — just a $50 price target.", "kpisCited": [ { "detail": "Lowered to $50 per share", "metric": "Price target" }, { "detail": "$69 million payment demand Valeant sent to R&O Pharmacy (which claimed no invoices exist)", "metric": "Disputed receivable" }, { "detail": "Approximately $69 million gross, ~$25 million in net revenue to Valeant", "metric": "Valeant shipments to R&O at WAC" }, { "detail": "(855) 815-7688 used by R&O, Philidor, West Wilshire, SafeRx, and Orbit", "metric": "Shared Privacy Officer phone number" }, { "detail": "0 years operating experience; 23-year McKinsey tenure (head of Global Pharma Practice) before joining in 2008", "metric": "Pearson pre-Valeant operating experience" } ], "closingAsk": "Extremely Cautious Investing to All — demand an explanation from Valeant before short sellers are blamed as they were at Enron.", "extraction": { "at": "2026-04-23 08:26:32+00", "model": "unknown-legacy", "runId": null, "seconds": 150.90128, "promptVersion": null }, "scqaReward": "Price target cut to $50 with material further downside if the captive-pharmacy revenue is confirmed fraudulent; Arthrocare precedent points to criminal exposure for leadership.", "thesisTypes": [ "fraud_exposure" ], "top3Reasons": [ "Philidor and R&O Pharmacy are the same entity — phantom accounts used to book revenue", "Valeant built a network of captive clone pharmacies (Orbit, West Wilshire, SafeRx) to stuff the channel", "Pattern mirrors Enron: McKinsey-bred CEO, hidden consolidation, rhetoric of being misunderstood" ], "scqaSituation": "Valeant is a hedge-fund-darling big-cap pharma that grew through serial acquisitions of Salix, Bausch & Lomb, and others, slashed R&D, and hiked drug prices aggressively under McKinsey-bred CEO J. Michael Pearson.", "thesisSummary": "Citron argues Valeant has constructed a network of captive specialty pharmacies — Philidor RX, R&O, West Wilshire, SafeRx, and Orbit — to manufacture phantom sales and evade auditor scrutiny. The smoking gun: R&O and Philidor share identical patient privacy notices, the same Privacy Officer toll-free number (855-815-7688), and the shell domains were all registered on the same day. Valeant's sudden disclosure that it holds an option to acquire Philidor and already consolidates its financials — revealed only after SIRF and NYT reporting forced the issue — is framed as a coverup, not transparency. Citron draws direct parallels to Enron (McKinsey-pedigree CEO, defensive rhetoric, 'simple model' claims) and to Arthrocare/Discocare, where a similar captive-pharmacy structure ended in a 20-year prison sentence for the CEO. Price target cut to $50.", "primaryDemands": [ "Investors should treat Valeant as a potential fraud and exit the stock", "Auditors and regulators should investigate the undisclosed Philidor relationship and captive-pharmacy network", "Board audit committee (chaired by Norma Provencio) should be held accountable for non-disclosure" ], "scqaResolution": "Investors should treat the Philidor disclosure as a coverup rather than transparency, absorb the Enron and Arthrocare precedents, and exit before regulators and auditors unwind the captive-pharmacy consolidation.", "thesisOneLiner": "Valeant is channel-stuffing through a web of captive specialty pharmacies (Philidor, R&O, plus cloned shells) to fabricate invoices and book phantom revenue — a potential Pharmaceutical Enron; price target $50.", "precedentsCited": [ "Enron (Skilling, Lay, Fastow rhetoric and collapse)", "Arthrocare / Discocare captive-pharmacy scheme (CEO sentenced to 20 years)", "Signalife / Mitchell Stein (Norma Provencio prior association)" ], "scqaComplication": "Philidor, a captive specialty pharmacy Valeant secretly consolidated, appears to own clone pharmacies (R&O, West Wilshire, SafeRx, Orbit) sharing phone numbers and privacy notices — evidence of fabricated invoices and channel-stuffed revenue hidden from auditors.", "narrativeInterest": 5, "notableSlidePages": [ 1, 2, 4, 6, 7 ], "peerCompaniesCited": [ "Enron", "Arthrocare", "Discocare", "Allergan", "Salix", "Bausch & Lomb" ], "valuationFrameworks": [ "not_shown" ], "visualCraftInterest": 3 }, "pitchdeck": { "metadata": null, "profile": null }, "slides": [ { "page": 1, "type": "tension", "title": "This is a classic short-seller research note designed to frame a company as a fraud (Enron comparison).", "function": "expose_contradiction", "imagePath": "https://imgproxy.kitesheet.com/gEYK1m4wSpmoesGpo9HP41Nntdtc8IFt3tTooD-KQl8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MzljMDZhZDFjMjcvcDAwMS5wbmc", "rawType": "executive_summary", "block": null, "metadata": { "slideType": "executive_summary", "slideTypeCanon": { "name": "Executive summary", "slug": "executive_summary", "status": "active", "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e", "version": 1, "description": null }, "function": "expose_contradiction", "functionCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-171f-776f-887c-73edaff4cf9c", "version": 1, "description": null }, "density": "overcrowded", "densityScore": 75, "componentCount": 9, "textChars": 1663, "nDataPoints": 1, "notes": "This is a classic short-seller research note designed to frame a company as a fraud (Enron comparison).", "elementsJson": [ "paragraph", "logo_grid" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:52:38.089+00", "seconds": 8.39, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622c-750b-8b9d-5bbf2c91b5c4/1", "deck": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4", "deckAnchor": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4#slide-1", "deckJson": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Valeant: Could this be the Pharmaceutical Enron?", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-22 23:17:17+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-14d8-75c0-8c92-78852cfbee60", "parentComponentId": null }, { "bbox": null, "kind": "metric", "text": "price target: $50", "attrs": null, "canon": { "kind": { "name": "Metric", "slug": "metric", "status": "active", "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d", "version": 1, "description": "Big-number or KPI value." }, "tool": { "name": "Quantification", "slug": "quantification", "status": "active", "bestFor": null, "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88", "version": 1, "bodyDocId": null, "description": "Translating a claim into numbers, charts, or tables.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-22 23:17:17+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-14d8-75c0-8c92-7dd49f5f98e0", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.78, "x": 0.11, "y": 0.72 }, "kind": "paragraph", "text": "With its quarterly earnings report scheduled for first thing Monday morning, Valeant was well aware of the scrutiny that was about to come down on Philidor and the R&O lawsuit, as both SIRF and the NYT had contacted management. Valeant came prepared for the conference call with pre-written questions and answers -- one about Philidor, and one about R&O -- in its slide deck. This is where the cover up begins.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:38.089+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "620c8e4b-b2ad-48de-9fc8-7f2217540ba1", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.78, "x": 0.11, "y": 0.44 }, "kind": "paragraph", "text": "On Monday morning before earnings, a report came out of SIRF, uncovering undisclosed relationships with specialty pharmas, namely Philidor RX. Most importantly, the article introduced Wall Street to a court filing made by a company called R&O Pharmacy, filed with the California District Court in September, in which this small regional pharmacy claims it had received an improper demand for payment from Valeant to the tune of $69 million.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:38.089+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6db2f96f-5211-4324-b52b-bfd35cf7e756", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.78, "x": 0.11, "y": 0.31 }, "kind": "paragraph", "text": "Just four days ago in the world of Valeant, no one had ever heard of Philidor RX. Recent concerns about the company focused on its unsavory business practices of massive prices raises on pharmaceuticals acquired in a rapid succession of acquisitions, while slashing research and development. But no one had discussed how these drugs were distributed....until this week.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:38.089+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "74ebe42b-f17c-4f66-bfb4-d40d1f4fa273", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.78, "x": 0.11, "y": 0.6 }, "kind": "paragraph", "text": "Just yesterday, the New York Times increased its scrutiny on Philidor by questioning if its operation was the target of subpoenas recently served on Valeant over its pricing strategy, covered the prior week.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:38.089+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ed8a50f6-06d6-4b5d-aa08-72ed5447501b", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.6, "x": 0.2, "y": 0.23 }, "kind": "title", "text": "Citron Publishes the Smoking Gun!! Price Target lowered to $50", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Action title", "slug": "action-title", "status": "active", "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d", "version": 1, "description": null }, "framework": null }, "subkind": "action-title", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:38.089+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5a0f580e-10c1-4f39-b37e-c017911541b6", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.7, "x": 0.15, "y": 0.19 }, "kind": "title", "text": "Valeant: Could this be the Pharmaceutical Enron?", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:38.089+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "36537c45-a56b-4b39-bfef-f973a6c6f3ce", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.78, "x": 0.11, "y": 0.67 }, "kind": "title", "text": "This is Not Where the Story Ends; it is Where the Story Begins", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:38.089+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ee5cbcad-13be-4f4c-8dee-492e6c9f9220", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "60026a5d-49de-43c3-8de7-7a4ad08a65f1", "evidence": "The slide explicitly frames the company as a 'Pharmaceutical Enron' and alleges a 'cover up'.", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 19:52:38.089+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 1, "frameworkName": "fraud-exposure" } ], "arcBeats": [ { "to": 1, "arc": { "name": "Overcoming the Monster", "slug": "overcoming-monster", "status": "active", "bestFor": "Competitive positioning, rallying teams", "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order", "description": null, "familyLabel": null }, "from": 1, "name": "Hook", "beatId": "84bf320e-4e89-448a-95ed-196717c0f56a", "matchId": "5693a768-917f-4653-b264-cf321b6c2750", "beatType": { "name": "Hook", "slug": "hook", "status": "active", "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5", "version": 1, "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster." }, "evidence": "The document begins with a provocative statement, 'Valeant: Could this be the Pharmaceutical Enron?'", "position": 0, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "thumbSrc": "https://imgproxy.kitesheet.com/_W2SlpS2_FgywQofi8YIHvtg64Xnf4Zog62P9gYmIkY/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MzljMDZhZDFjMjcvcDAwMS5wbmc", "imagePathAlt": "https://imgproxy.kitesheet.com/toWRJXQsdrxCWo0rzofGjeXjheRfszUvFXXgzAMFU9Q/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MzljMDZhZDFjMjcvcDAwMS5qcGc", "thumbSrcAlt": "https://imgproxy.kitesheet.com/gPgFzqejGFwfwlmbAzgKBbyVkP2-2WHLIDX3wPU7m4Q/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84MzljMDZhZDFjMjcvcDAwMS5qcGc" }, { "page": 2, "type": "appendix", "title": "Image file at /tmp/legacy-images/839c06ad1c27/slides/002.jpg was not present on disk; could not inspect content.", "function": "other", "rawType": "other", "block": null, "metadata": { "slideType": "other", "slideTypeCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43", "version": 1, "description": null }, "function": "other", "functionCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce", "version": 1, "description": null }, "density": "sparse", "densityScore": 0, "componentCount": null, "textChars": null, "nDataPoints": 0, "notes": "Image file at /tmp/legacy-images/839c06ad1c27/slides/002.jpg was not present on disk; could not inspect content.", "elementsJson": null, "confidence": 0, "extraction": { "model": "claude-cli", "runId": null, "at": "2026-05-03 02:54:11.123+00", "seconds": null, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622c-750b-8b9d-5bbf2c91b5c4/2", "deck": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4", "deckAnchor": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4#slide-2", "deckJson": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4.json" }, "components": [], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "locked": true }, { "page": 3, "type": "tension", "title": "This is a page from a Citron Research short report on Valeant Pharmaceuticals.", "function": "expose_contradiction", "rawType": "expose_contradiction", "block": null, "metadata": { "slideType": "expose_contradiction", "slideTypeCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df", "version": 1, "description": null }, "function": "expose_contradiction", "functionCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-171f-776f-887c-73edaff4cf9c", "version": 1, "description": null }, "density": "balanced", "densityScore": 43, "componentCount": 7, "textChars": 892, "nDataPoints": 0, "notes": "This is a page from a Citron Research short report on Valeant Pharmaceuticals.", "elementsJson": [ "paragraph", "headline_text", "screenshot", "callout_box" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:52:32.947+00", "seconds": 3.076, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622c-750b-8b9d-5bbf2c91b5c4/3", "deck": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4", "deckAnchor": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4#slide-3", "deckJson": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Citron believes the whole thing is a fraud to create invoices to deceive the auditors and book revenue.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-22 23:17:16+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-14d8-75c0-8c92-382b327f2f2f", "parentComponentId": null }, { "bbox": { "h": 0.32, "w": 0.76, "x": 0.118, "y": 0.44 }, "kind": "image", "text": "R&O Pharmacy Notice of Privacy Practices document snippet", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Screenshot", "slug": "screenshot", "status": "active", "canonId": "019de52c-fd87-7509-8391-3d79fb339379", "version": 1, "description": null }, "framework": null }, "subkind": "screenshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:32.947+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "04abfbce-fee6-4f45-8b3b-0e73711f00ce", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.76, "x": 0.118, "y": 0.24 }, "kind": "paragraph", "text": "Citron believes the whole thing is a fraud to create invoices to deceive the auditors and book revenue. PHANTOM ACCOUNTS. Here is the reasoning.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:32.947+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "4c801087-89ae-44dc-92bd-85cdbae284a7", "parentComponentId": null }, { "bbox": { "h": 0.08, "w": 0.76, "x": 0.118, "y": 0.34 }, "kind": "paragraph", "text": "From the links below, it is obvious that Philidor and R&O are ARE THE SAME COMPANY AND SHARE MANAGEMENT. The two companies have the same patient privacy disclosure, in fact formatted identically, on both companies' websites. Note the R&O website refers to themselves as Philidor.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:32.947+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c375f34a-50de-423f-8bd6-9604e4669adc", "parentComponentId": null }, { "bbox": { "h": 0.15, "w": 0.76, "x": 0.118, "y": 0.09 }, "kind": "paragraph", "text": "a bit far-fetched, but it was somewhat plausible if you wanted to suspend all disbelief. But after a fair amount of due diligence Citron is about to post the line that should send alarm through all Valeant shareholders: Philidor Owns R&O Pharmacy.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:32.947+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c8f9a123-cb5d-4ab9-92ea-b925a07be158", "parentComponentId": null }, { "bbox": { "h": 0.02, "w": 0.35, "x": 0.32, "y": 0.76 }, "kind": "source-note", "text": "http://randopharmacy.com/downloads/ro_npp.pdf", "attrs": null, "canon": { "kind": { "name": "Source note", "slug": "source-note", "status": "active", "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948", "version": 1, "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:32.947+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "91eb1a2d-ddd0-4a97-9d3f-6a429148df24", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.28, "x": 0.118, "y": 0.307 }, "kind": "title", "text": "The Smoking Gun!!", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:32.947+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c590ebfb-cb4c-48d0-8021-a9bedbd1394a", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "7358d372-0955-4015-84d8-19118616afb4", "evidence": "The slide explicitly claims 'fraud to create invoices to deceive the auditors'", "framework": null, "confidence": 1, "extraction": { "at": "2026-05-02 19:52:32.947+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 3, "frameworkName": "fraud-exposure" } ], "arcBeats": [ { "to": 7, "arc": { "name": "Overcoming the Monster", "slug": "overcoming-monster", "status": "active", "bestFor": "Competitive positioning, rallying teams", "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order", "description": null, "familyLabel": null }, "from": 3, "name": "Expose Contradiction", "beatId": "4ae2007e-94c8-4629-918a-6139bd346d3d", "matchId": "5693a768-917f-4653-b264-cf321b6c2750", "beatType": null, "evidence": "The document presents a series of contradictions and coincidences that suggest a connection between Valeant and Philidor Rx Services and R&O Pharmacy", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 4, "from": 3, "loop": { "name": "03_aha_moment", "slug": "03-aha-moment", "status": "active", "bestFor": "Data-heavy sections, research findings, analytical arguments", "canonId": "019dd956-66f4-7668-ab25-cec9c996c0bc", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "description": "Establish a tension, present data, then deliver the insight that changes everything", "familyLabel": null }, "matchId": "96843e19-c8e5-42dc-a5c3-ed0b532f722e", "evidence": "The document presents evidence of identical contact information and phone routing, suggesting a connection between the entities", "position": 0, "objective": "What is the nature of the relationship between Valeant and Philidor Rx Services and R&O Pharmacy?", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:04:09.830593+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 4, "type": "tension", "title": "Includes red annotations circling phone numbers and drawing a connection between two contact blocks.", "function": "expose_contradiction", "rawType": "expose_contradiction", "block": null, "metadata": { "slideType": "expose_contradiction", "slideTypeCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df", "version": 1, "description": null }, "function": "expose_contradiction", "functionCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-171f-776f-887c-73edaff4cf9c", "version": 1, "description": null }, "density": "balanced", "densityScore": 36, "componentCount": 7, "textChars": 609, "nDataPoints": 0, "notes": "Includes red annotations circling phone numbers and drawing a connection between two contact blocks.", "elementsJson": [ "screenshot", "paragraph" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:52:36.182+00", "seconds": 6.305, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622c-750b-8b9d-5bbf2c91b5c4/4", "deck": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4", "deckAnchor": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4#slide-4", "deckJson": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "If you dial the fax # on the R&O website and press 1, you will get Philidor RX. It does not stop at an R&O phone.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-22 23:17:17+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-14d8-75c0-8c93-1ffeef778d87", "parentComponentId": null }, { "bbox": { "h": 0.285, "w": 0.764, "x": 0.118, "y": 0.092 }, "kind": "image", "text": "Philidor Rx Services Notice of Privacy Practices", "attrs": null, "canon": { "kind": { "name": "Image", "slug": "image", "status": "active", "canonId": "019de52c-f978-701f-a720-51d029d769e7", "version": 1, "description": "Photo, illustration, screenshot or icon." }, "tool": null, "subkind": { "name": "Screenshot", "slug": "screenshot", "status": "active", "canonId": "019de52c-fd87-7509-8391-3d79fb339379", "version": 1, "description": null }, "framework": null }, "subkind": "screenshot", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:36.182+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c0542d9d-0fa7-40df-a864-d2a588f9ba63", "parentComponentId": null }, { "bbox": { "h": 0.25, "w": 0.3, "x": 0.36, "y": 0.52 }, "kind": "legend", "text": "Red circles and lines highlighting identical phone numbers", "attrs": null, "canon": { "kind": { "name": "Legend", "slug": "legend", "status": "active", "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c", "version": 1, "description": "Color/symbol decoder placed adjacent to a chart or diagram." }, "tool": null, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:36.182+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "6c9f2f90-5d65-47ee-a273-4801a41b42f1", "parentComponentId": null }, { "bbox": { "h": 0.055, "w": 0.764, "x": 0.118, "y": 0.461 }, "kind": "paragraph", "text": "And look! The pharmacies -- R&O, in Camarillo California, and Philidor RX in Horsham PA, have the identical toll free number to reach their Privacy Officer (at the bottom.) Now that's some service!", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:36.182+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "1af154b9-4ce5-4a19-9a1f-dd6914360b7d", "parentComponentId": null }, { "bbox": { "h": 0.045, "w": 0.764, "x": 0.118, "y": 0.805 }, "kind": "paragraph", "text": "If you dial the fax # on the R&O website and press 1, you will get Philidor RX. It does not stop at an R&O phone.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:36.182+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "af7bc2c2-dc79-49b2-b737-e16bec9f0122", "parentComponentId": null }, { "bbox": { "h": 0.075, "w": 0.764, "x": 0.118, "y": 0.688 }, "kind": "table", "text": "Contact information for Philidor Rx Services", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:36.182+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5d7d2f51-f8f0-4d10-9042-03733cb78f7a", "parentComponentId": null }, { "bbox": { "h": 0.075, "w": 0.764, "x": 0.118, "y": 0.561 }, "kind": "table", "text": "Contact information for R&O Pharmacy", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:36.182+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "9cfd9571-ec3c-4b1b-a47d-7a6659e46989", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "08a74e6b-f6d5-41cf-a26a-507c8121857b", "evidence": "The slide uses evidence of shared contact details to expose a hidden relationship between two entities.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:52:36.182+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 4, "frameworkName": "fraud-exposure" } ], "arcBeats": [ { "to": 7, "arc": { "name": "Overcoming the Monster", "slug": "overcoming-monster", "status": "active", "bestFor": "Competitive positioning, rallying teams", "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order", "description": null, "familyLabel": null }, "from": 3, "name": "Expose Contradiction", "beatId": "4ae2007e-94c8-4629-918a-6139bd346d3d", "matchId": "5693a768-917f-4653-b264-cf321b6c2750", "beatType": null, "evidence": "The document presents a series of contradictions and coincidences that suggest a connection between Valeant and Philidor Rx Services and R&O Pharmacy", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 4, "from": 3, "loop": { "name": "03_aha_moment", "slug": "03-aha-moment", "status": "active", "bestFor": "Data-heavy sections, research findings, analytical arguments", "canonId": "019dd956-66f4-7668-ab25-cec9c996c0bc", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "description": "Establish a tension, present data, then deliver the insight that changes everything", "familyLabel": null }, "matchId": "96843e19-c8e5-42dc-a5c3-ed0b532f722e", "evidence": "The document presents evidence of identical contact information and phone routing, suggesting a connection between the entities", "position": 0, "objective": "What is the nature of the relationship between Valeant and Philidor Rx Services and R&O Pharmacy?", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:04:09.830593+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 5, "type": "tension", "title": "This is a page from a short-seller research report (Citron Research) targeting Valeant Pharmaceuticals.", "function": "expose_contradiction", "rawType": "expose_contradiction", "block": null, "metadata": { "slideType": "expose_contradiction", "slideTypeCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df", "version": 1, "description": null }, "function": "expose_contradiction", "functionCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-171f-776f-887c-73edaff4cf9c", "version": 1, "description": null }, "density": "dense", "densityScore": 73, "componentCount": 9, "textChars": 1754, "nDataPoints": 0, "notes": "This is a page from a short-seller research report (Citron Research) targeting Valeant Pharmaceuticals.", "elementsJson": [ "paragraph" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:52:34.288+00", "seconds": 4.073, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622c-750b-8b9d-5bbf2c91b5c4/5", "deck": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4", "deckAnchor": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4#slide-5", "deckJson": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Citron believes it is merely for the purpose of phantom sales or stuff the channel, and avoid scrutiny from the auditors.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-22 23:17:17+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-14d8-75c0-8c93-0f5a4ee51f6d", "parentComponentId": null }, { "bbox": { "h": 0.07, "w": 0.5, "x": 0.11, "y": 0.16 }, "kind": "list", "text": "http://westwilshirepharma.com/downloads/ww_npp.pdf\nhttp://saferxpharma.com/downloads/saferx_npp.pdf\nhttp://orbitpharmacy.com/downloads/orbit_npp.pdf", "attrs": null, "canon": { "kind": { "name": "List", "slug": "list", "status": "active", "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2", "version": 1, "description": "Bullet or numbered list." }, "tool": null, "subkind": { "name": "Bullet list", "slug": "bullet", "status": "active", "canonId": "019de52c-fc98-7169-a083-5cab805076ca", "version": 1, "description": null }, "framework": null }, "subkind": "bullet", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.288+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d393a602-8c1b-44ef-9d20-d324b1d9901b", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.78, "x": 0.11, "y": 0.09 }, "kind": "paragraph", "text": "And as if this isn't enough, it appears to Citron that Valeant/Philidor have created an entire network of phantom captive pharmacies ... the same privacy notice appears on several other \"ghost ship\" putative pharmacy websites.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.288+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "140431bf-ffdd-47b0-bf46-f8ef6cb54eee", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.78, "x": 0.11, "y": 0.69 }, "kind": "paragraph", "text": "These similarities are too close to ignore. Does everyone remember during the Allergan takeover battle, when Allergan chose the words \"house of cards\" ? Look at the following similarities between statements by Valeant and those of Enron:", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.288+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "3251b25f-a487-4032-83e6-68037799c5c9", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.78, "x": 0.11, "y": 0.32 }, "kind": "paragraph", "text": "It is apparent to Citron that Valeant has created a network of \"pharmacies\" as clones of Philidor. Why do these exist? Citron believes it is merely for the purpose of phantom sales or stuff the channel, and avoid scrutiny from the auditors.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.288+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5c9c5ed0-f40e-4119-8454-9d4b632b026d", "parentComponentId": null }, { "bbox": { "h": 0.11, "w": 0.78, "x": 0.11, "y": 0.5 }, "kind": "paragraph", "text": "Let us not forget that the head of the Valeant audit committee is Norma Provencio. Mrs. Provencio herself was a director of Signalife which was run by now convicted stock fraudster Mitchell Stein. She was in fact his close associate for years -- information now conveniently omitted from her biography. Mrs. Provencio's integrity was first challenged by Bronte Capital in this posting you should read for yourself. Now the relevance of its full context becomes clear.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.288+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d66fd688-7da5-44f9-86ae-226ad5290b7f", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.78, "x": 0.11, "y": 0.25 }, "kind": "paragraph", "text": "Oh, and as by mere coincidence, these all have the same Privacy Officer contact phone number: (855) 815-7688. And these domains were all registered on the same day! [ Click Here to See them all ]", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.288+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "f6e0e0c3-8beb-4643-8eba-cc38a4180972", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.78, "x": 0.11, "y": 0.42 }, "kind": "title", "text": "How Can This Be, Citron ? Doesn't the Head of the Audit Committee have Any Responsibility Here?", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.288+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "0f63d16c-50c8-41e0-9e44-102e5d9b05c7", "parentComponentId": null }, { "bbox": { "h": 0.03, "w": 0.3, "x": 0.11, "y": 0.65 }, "kind": "title", "text": "Is this Enron part Deux??", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.288+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "fc63f58d-0314-433d-8e8c-6e47ff5355bb", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 7, "arc": { "name": "Overcoming the Monster", "slug": "overcoming-monster", "status": "active", "bestFor": "Competitive positioning, rallying teams", "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order", "description": null, "familyLabel": null }, "from": 3, "name": "Expose Contradiction", "beatId": "4ae2007e-94c8-4629-918a-6139bd346d3d", "matchId": "5693a768-917f-4653-b264-cf321b6c2750", "beatType": null, "evidence": "The document presents a series of contradictions and coincidences that suggest a connection between Valeant and Philidor Rx Services and R&O Pharmacy", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 6, "type": "tension", "title": "The slide uses a 'vs.' structure to draw parallels between Enron and Valeant, implying a pattern of behavior.", "function": "expose_contradiction", "rawType": "expose_contradiction", "block": null, "metadata": { "slideType": "expose_contradiction", "slideTypeCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df", "version": 1, "description": null }, "function": "expose_contradiction", "functionCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-171f-776f-887c-73edaff4cf9c", "version": 1, "description": null }, "density": "balanced", "densityScore": 30, "componentCount": 2, "textChars": 1400, "nDataPoints": 0, "notes": "The slide uses a 'vs.' structure to draw parallels between Enron and Valeant, implying a pattern of behavior.", "elementsJson": [ "comparison_table" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:52:32.45+00", "seconds": 2.146, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622c-750b-8b9d-5bbf2c91b5c4/6", "deck": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4", "deckAnchor": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4#slide-6", "deckJson": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4.json" }, "components": [ { "bbox": null, "kind": "quote", "text": "It is unfair to us and unethical if you don't take the time to understand our business... we are doing it purely right... people who raise questions are people who have not gone through our business in detail... — Enron CEO Jeff Skilling; So again, it is unfortunate that Allergan has not taken the time to understand our business... There is a number of inaccuracies in the report that was put out yesterday... They are just factually incorrect... — Valeant Chairman, CEO Michael Pearson; [Enron] is a very simple model... it is a logistics company, not a trading company. — Enron CEO Jeff Skilling; [Valeant] is more like a professional services firm than a sort of traditional pharmaceutical company. — Valeant Chairman, CEO Michael Pearson; [Enron's] disclosure is more complete than anyone's. — Enron CFO Andy Fastow; I will also point out that Valeant gives massively more disclosure about its business and did so prior to this transaction than Allergan. — Bill Ackman; I have never felt better about the prospects of the Company... our growth has never been more certain. — Enron Chairman, Ken Lay; As we look across the entire business, I have never been more confident about the growth trajectory across the entire company. — Valeant Chairman, CEO Michael Pearson", "attrs": null, "canon": { "kind": { "name": "Quote", "slug": "quote", "status": "active", "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a", "version": 1, "description": "Pull quote or testimonial." }, "tool": { "name": "Authority citation", "slug": "authority-citation", "status": "active", "bestFor": null, "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45", "version": 1, "bodyDocId": null, "description": "Quoting an authority figure, study, or precedent to lend weight.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-22 23:17:18+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-14d9-722b-8538-3a5199ab38e4", "parentComponentId": null }, { "bbox": { "h": 0.8, "w": 0.8, "x": 0.1, "y": 0.08 }, "kind": "table", "text": "Four pairs of quotes comparing Enron and Valeant executives on themes of business complexity, disclosure, and growth confidence.", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:32.45+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "c27f2a08-1cf1-488f-be70-ff1da4f893d2", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "444500cf-bdbf-44c8-9768-5c13b4e22fb9", "evidence": "Direct comparison of executive quotes to highlight patterns of behavior.", "framework": null, "confidence": 0.95, "extraction": { "at": "2026-05-02 19:52:32.45+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 6, "frameworkName": "ceo-quote-contradiction" } ], "arcBeats": [ { "to": 7, "arc": { "name": "Overcoming the Monster", "slug": "overcoming-monster", "status": "active", "bestFor": "Competitive positioning, rallying teams", "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order", "description": null, "familyLabel": null }, "from": 3, "name": "Expose Contradiction", "beatId": "4ae2007e-94c8-4629-918a-6139bd346d3d", "matchId": "5693a768-917f-4653-b264-cf321b6c2750", "beatType": null, "evidence": "The document presents a series of contradictions and coincidences that suggest a connection between Valeant and Philidor Rx Services and R&O Pharmacy", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [], "locked": true }, { "page": 7, "type": "tension", "title": "Uses a historical precedent (Arthrocare) to frame the current Valeant investigation.", "function": "expose_contradiction", "rawType": "expose_contradiction", "block": null, "metadata": { "slideType": "expose_contradiction", "slideTypeCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df", "version": 1, "description": null }, "function": "expose_contradiction", "functionCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-171f-776f-887c-73edaff4cf9c", "version": 1, "description": null }, "density": "balanced", "densityScore": 43, "componentCount": 7, "textChars": 689, "nDataPoints": 4, "notes": "Uses a historical precedent (Arthrocare) to frame the current Valeant investigation.", "elementsJson": [ "headline_text", "paragraph", "comparison_table", "callout_box" ], "confidence": 1, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:52:34.361+00", "seconds": 3.42, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622c-750b-8b9d-5bbf2c91b5c4/7", "deck": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4", "deckAnchor": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4#slide-7", "deckJson": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4.json" }, "components": [ { "bbox": null, "kind": "callout", "text": "Citron has seen this movie before.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-22 23:17:18+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-14d9-722b-8538-a0a4d6348370", "parentComponentId": null }, { "bbox": { "h": 0.285, "w": 0.786, "x": 0.107, "y": 0.375 }, "kind": "paragraph", "text": "Citron has seen this movie before. In 2008, Arthrocare... The CEO of Arthrocare is now doing 20 years. While it is impossible for Citron to state for certain at this point, this has the distinct aroma of product being jammed into a channel.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.361+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "41ab8ffe-8e36-4b04-9b85-bbd424a81ff8", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.786, "x": 0.107, "y": 0.855 }, "kind": "paragraph", "text": "Citron Research has delivered the proof that something really stinks at Valeant and it is goes beyond their egregious price hikes", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.361+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e363174f-74c7-445a-a8b2-57fa665aeb00", "parentComponentId": null }, { "bbox": { "h": 0.05, "w": 0.786, "x": 0.107, "y": 0.785 }, "kind": "quote", "text": "All truths are easy to understand once they are discovered; the point is to discover them......Galileo Galilei", "attrs": null, "canon": { "kind": { "name": "Quote", "slug": "quote", "status": "active", "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a", "version": 1, "description": "Pull quote or testimonial." }, "tool": null, "subkind": { "name": "Pull quote", "slug": "pull-quote", "status": "active", "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9", "version": 1, "description": null }, "framework": null }, "subkind": "pull-quote", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.361+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "d36267bd-2f1c-480e-b355-0833028af16b", "parentComponentId": null }, { "bbox": { "h": 0.215, "w": 0.786, "x": 0.107, "y": 0.135 }, "kind": "table", "text": "Jeff Skilling Bio: 0 years experience, McKinsey background. Michael Pearson Bio: 0 years experience, McKinsey background.", "attrs": null, "canon": { "kind": { "name": "Table", "slug": "table", "status": "active", "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28", "version": 1, "description": "Tabular data layout." }, "tool": null, "subkind": { "name": "Data table", "slug": "data", "status": "active", "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569", "version": 1, "description": null }, "framework": null }, "subkind": "data", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.361+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "e49d199d-d299-4a57-a2c6-f9a201aa0cd6", "parentComponentId": null }, { "bbox": { "h": 0.04, "w": 0.64, "x": 0.18, "y": 0.725 }, "kind": "title", "text": "Conclusion", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.361+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "19ed9df3-a5d6-4b64-bee9-a45881fc8af1", "parentComponentId": null }, { "bbox": { "h": 0.025, "w": 0.595, "x": 0.107, "y": 0.095 }, "kind": "title", "text": "This is just too much of an eerie coincidence", "attrs": null, "canon": { "kind": { "name": "Title", "slug": "title", "status": "active", "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4", "version": 1, "description": "Slide title or headline." }, "tool": null, "subkind": { "name": "Headline", "slug": "headline", "status": "active", "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d", "version": 1, "description": null }, "framework": null }, "subkind": "headline", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:34.361+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "b9880e91-5e3c-4f98-9800-e2ba7b5d43a4", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "679ddaef-f18b-4b13-9dcc-11b9a97a11e6", "evidence": "Compares Valeant/Philidor situation to the historical Arthrocare/Discocare fraud case.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:52:34.361+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 7, "frameworkName": "argument-from-analogy" } ], "arcBeats": [ { "to": 7, "arc": { "name": "Overcoming the Monster", "slug": "overcoming-monster", "status": "active", "bestFor": "Competitive positioning, rallying teams", "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e", "version": 1, "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49", "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order", "description": null, "familyLabel": null }, "from": 3, "name": "Expose Contradiction", "beatId": "4ae2007e-94c8-4629-918a-6139bd346d3d", "matchId": "5693a768-917f-4653-b264-cf321b6c2750", "beatType": null, "evidence": "The document presents a series of contradictions and coincidences that suggest a connection between Valeant and Philidor Rx Services and R&O Pharmacy", "position": 1, "isPrimaryArc": true, "parentBeatType": null, "alignedBlockIds": null, "matchConfidence": 0.8 } ], "loops": [ { "to": 7, "from": 7, "loop": { "name": "05_the_reveal", "slug": "05-the-reveal", "status": "active", "bestFor": "Product launches, strategic pivots, unexpected findings", "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd", "version": 1, "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21", "structure": "Setup the Question -> Build Suspense -> The Big Reveal", "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion", "familyLabel": null }, "matchId": "21e4a757-d53c-4694-acc3-2922986a9e40", "evidence": "The document suggests that the connection between Valeant and Philidor Rx Services and R&O Pharmacy indicates potential wrongdoing", "position": 1, "objective": "What are the implications of this connection?", "confidence": 0.7, "extraction": { "at": "2026-07-16 22:04:09.869248+00", "model": "or:meta-llama/llama-4-scout", "runId": null, "seconds": null, "promptVersion": "doc-narrative-v1" } } ], "locked": true }, { "page": 8, "type": "appendix", "title": "The slide uses a historical analogy (Enron/Lay/Skilling) to frame the current Valeant situation as a deception.", "function": "expose_contradiction", "rawType": "other", "block": null, "metadata": { "slideType": "other", "slideTypeCanon": { "name": "Other (fallback)", "slug": "other", "status": "active", "canonId": "019de52d-0af5-71ed-83de-d51ae245fc43", "version": 1, "description": null }, "function": "expose_contradiction", "functionCanon": { "name": "Expose contradiction", "slug": "expose_contradiction", "status": "active", "canonId": "019de52d-171f-776f-887c-73edaff4cf9c", "version": 1, "description": null }, "density": "sparse", "densityScore": 17, "componentCount": 4, "textChars": 541, "nDataPoints": 0, "notes": "The slide uses a historical analogy (Enron/Lay/Skilling) to frame the current Valeant situation as a deception.", "elementsJson": [ "paragraph" ], "confidence": 0.9, "extraction": { "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "at": "2026-05-02 19:52:33.494+00", "seconds": 2.431, "promptVersion": "v2-canon-conditioned" } }, "links": { "slide": "/slides/019dd923-622c-750b-8b9d-5bbf2c91b5c4/8", "deck": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4", "deckAnchor": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4#slide-8", "deckJson": "/decks/019dd923-622c-750b-8b9d-5bbf2c91b5c4.json" }, "components": [ { "bbox": { "h": 0.03, "w": 0.3, "x": 0.118, "y": 0.315 }, "kind": "callout", "text": "Extremely Cautious Investing to All", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": null, "subkind": { "name": "Primary callout", "slug": "primary", "status": "active", "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d", "version": 1, "description": null }, "framework": null }, "subkind": "primary", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:33.494+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "97ad20b2-f045-44fe-805d-549024ef8489", "parentComponentId": null }, { "bbox": null, "kind": "callout", "text": "All of a sudden, one thread unravels this whole web of deception.", "attrs": null, "canon": { "kind": { "name": "Callout", "slug": "callout", "status": "active", "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2", "version": 1, "description": "Highlighted callout box." }, "tool": { "name": "Visual emphasis", "slug": "visual-emphasis", "status": "active", "bestFor": null, "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c", "version": 1, "bodyDocId": null, "description": "Drawing the eye to one element above the rest of the slide.", "familyLabel": null }, "subkind": null, "framework": null }, "subkind": null, "groupRole": null, "confidence": null, "extraction": { "at": "2026-04-22 23:17:17+00", "model": "unknown-legacy", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "019dd953-14d8-75c0-8c92-69de1501267c", "parentComponentId": null }, { "bbox": { "h": 0.12, "w": 0.77, "x": 0.118, "y": 0.106 }, "kind": "paragraph", "text": "All of a sudden, one thread unravels this whole web of deception. From the moment of the first public mention of Philidor, within 72 hours, Valeant is now holding an option to acquire Philidor and investors find out only in retrospect that Valeant has been consolidating Philidor financials?", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:33.494+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "5fa52e16-d507-43c4-95db-a09aab31ed5d", "parentComponentId": null }, { "bbox": { "h": 0.06, "w": 0.77, "x": 0.118, "y": 0.235 }, "kind": "paragraph", "text": "Let's get the explanation -- Certainly Mr. Lay and Skilling had one all the way down to the trial -- and in which they still blamed the short sellers.", "attrs": null, "canon": { "kind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4", "version": 1, "description": "Single prose block in the body of a slide." }, "tool": null, "subkind": { "name": "Paragraph", "slug": "paragraph", "status": "active", "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433", "version": 1, "description": null }, "framework": null }, "subkind": "paragraph", "groupRole": null, "confidence": null, "extraction": { "at": "2026-05-02 19:52:33.494+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "componentId": "ca7eb8be-bb70-4374-9429-d656d1526811", "parentComponentId": null } ], "metrics": [], "tools": [], "frameworks": [ { "matchId": "e8a1d8d6-d53b-4c6e-b835-82e911f7bd13", "evidence": "Compares Valeant's situation to the Enron scandal involving Lay and Skilling.", "framework": null, "confidence": 0.9, "extraction": { "at": "2026-05-02 19:52:33.494+00", "model": "google/gemini-3.1-flash-lite-preview-20260303", "runId": null, "seconds": null, "promptVersion": null }, "pageNumber": 8, "frameworkName": "metaphor-analogy" } ], "arcBeats": [], "loops": [], "locked": true } ], "arcBeats": [ { "from": 1, "to": 1, "label": "Hook", "description": "The document begins with a provocative statement, 'Valeant: Could this be the Pharmaceutical Enron?'" }, { "from": 3, "to": 7, "label": "Expose Contradiction", "description": "The document presents a series of contradictions and coincidences that suggest a connection between Valeant and Philidor Rx Services and R&O Pharmacy" } ], "loops": [ { "from": 3, "to": 4, "label": "Aha Moment", "description": "What is the nature of the relationship between Valeant and Philidor Rx Services and R&O Pharmacy?" }, { "from": 7, "to": 7, "label": "The Reveal", "description": "What are the implications of this connection?" } ] }